REGISTRATION OPEN FOR MD/MS & MDS PROGRAMMES Apply Now

Admissions Open Apply now

icon

Dr Ankur Sharma

Assistant Professor, Life Science

ankur.sharma7@sharda.ac.in

About

Dr Ankur Sharma, is an experienced research cum teaching professional in the area of Biotechnology and Nanotechnology. I have done my Ph.D in Life and Health Sciences from Ulster university (United Kingdom). I did my masters in Bionanotechnology from The University of Sheffield (United Kingdom). I have expertise in domains like Nanomedicine, Cancer biology and Neuro-oncology. I have published various international peer-reviewed papers.

Experience
  • 5 Years
Qualification
  • Ph.D
Research

  • A “NOTCH” deeper into the Epithelial-to-Mesenchymal Transition (EMT) program in Breast cancer Rohan Kar, Saurabh Jha, Ankur Sharma, Nidhi Asthana, Kundan Chaurisiya, Vivek Singh, Shuaib Burgee, Parma Nand, Niraj Jha * (Journal- Genes, Impact factor- 3.31, Year -2019)
  • Anti-invasive and anti-proliferative effects of shRNA-loaded poly(lactide-co-glycolide) nanoparticles following RAN silencing in MDA-MB231 breast cancer cells Sharma A1, Matchett KB2, McCarron PA1, El-Tanani M3, *Hawthorne SJ1 (Pharmaceutical Research Journal- Impact Factor-3.8, Year -2019)
  • Abstract in at National Conference on BioTrendz: Technological Advancement & Challenges in the Field of Biotechnology” 2019, NIIT, India “Are Stem Cells the next Frontier for therapy of Amyotrophic Lateral Sclerosis?” Shalu Mishra1*, Neetesh Chauhan1*, Kumari Swati3, Abhishek Wilson2, Ankur Sharma2, Parma Nand1, Parbhu Chandra Mishra3 and Saurabh Kumar Jha1, 2 †
  • Abstract in at National Conference on BioTrendz: Technological Advancement & Challenges in the Field of Biotechnology”_2019, NIIT, India“In slico study of Parkin and their therapeutic approaches in Neurodegenerative disorder” Ankita Singh1, Kumari Swati3, Abhishek Wilson2, Ankur Sharma2, Parbhu Chandra Mishra3 and Saurabh Kumar Jha1, 2 †
  • Abstract in at 36th All Ireland School of Pharmacy Conference 2014 (April), Dublin, Ireland “Preparation, Characterization and, in vivo evaluation of insulin loaded PLGA-PEG nanoparticles for controlled delivery” Y. Haggag , A. Sharma, M. Osman, S. Elgizawy, P. McCarron, A. Faheem
  • Abstract in at American Association of Pharmaceutical Scientists (AAPS) conference, 2014 (November), San Diego, USA“Assessment of Insulin Stability In PLGA-PEG Nanoparticles Prepared by the Double Emulsion Solvent Evaporation Technique Y. Haggag, A. Sharma, O. Opeolu, Y.Abdel-Waheb,  M.Osman, S. Elgizaway, P. McCarron, A. Faheem
  • Abstract in 6th APS International pharmc Sci conference, September 2015, Nottingham, England (United Kingdom) “Evaluation of Biodegradable Nanoparticles as a potential shRNA delivery system for anti-metastatic  RanGTPase Biotherapeutics” Sharma A1, McCarron PA1, El-Tanani M2, Faheem A, Hawthorne SJ1
  • Abstract in at American Association of Pharmaceutical Scientists (AAPS) conference, 2015 (October), Orland, Florida, USA “In-vitro evaluation of shRNA Nanoparticles for anti-metastasis RanGTPase Biotherapeutics” Sharma A1, McCarron PA1, El-Tanani M2, Hawthorne SJ1

Book Chapters

  • “Alterations in Metabolite-driven Gene Regulation in Cancer Metabolism” Saurabh Kumar Jha1*, Rahul Yadav2, Kumari Swati1, Niraj Kumar Jha1 , Ankur Sharma2 , Fahad Khan3 , Neeraj Kumar4 , Parma Nand1 , Prabhjot Kaur2, Tanaya Gover2 and Geetika Rawat2 (Publishing House- Springer Publication, 1-11-2019, Under revision)
  • “Clinical relevance of “Diagnostic markers” in cancer metabolism” Niraj Kumar Jha1*, Saurabh Kumar Jha1, Ankur Sharma2 , Rahul Yadav2, Pratibha Pandey3 , Kavindra Kumar Kesari4 , Neeraj Kumar5 , Parma Nand1 , Mansi Agrahari2 and Nancy Sanjay Gupta (Publishing House- Springer Publication, 1-11-2019, Submitted, Under revision)

Area of Interest

  • Nanomedicine
  • Neuro-oncology
  • Cancer biology